Schematic illustration highlighting targets of senotherapeutics including senolytics and senomorphics
Schematic illustration highlighting targets of senotherapeutics including senolytics and senomorphics. Senolytics induce apoptosis in senescent cells by targeting key enzymes involved in anti-apoptotic and pro-survival mechanisms, such as tyrosine kinase (TK), p53, B-cell lymphoma-2 (Bcl-2) family proteins, serine/threonine protein kinase (AKT), phosphatidylinositol 3-kinase (PI3K) and forkhead box O protein (FOXO). Dasatinib is a TK inhibitor able to inhibit cell proliferation and induce apoptosis. (Figure 3) Quercetin is a flavonoid, which interacts with a PI3K isoform and Bcl-2 family members. Glycoprotein nonmetastatic melanoma protein B (GPNMB) and urokinase-type plasminogen activator receptor (uPAR) are seno-antigens broadly expressed on senescent cells. Peptide vaccination against GPNMB and CAR-T cells directed against uPAR can remove senescent cells. Senomorphics suppress SASP cell function by neutralizing SASP components or by interacting with their transcriptional regulators. Rapamycin inhibits the mammalian target of rapamycin (mTOR) signaling and decreases nuclear factor kappa B (NF-κB) activity to reduce interleukin 1α (IL-1α) production. Metformin and statins inhibit the mTOR signaling pathway. Aspirin increases nitric oxide synthesis and decreases oxidative stress, consequently up-regulates telomerase activity. Angiotensin-converting-enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs, formally AT1R blockers) prevent telomeric and non-telomeric deoxyribonucleic acid (DNA) damage of angiotensin II through reactive oxygen species (ROS) mediated oxidative stress. Resveratrol activates sirtuins that regulate cellular senescence via targeting NF-κB transcription factors. Cytokine targeting therapy includes Xilonix, which is a monoclonal antibody specifically targeting IL-1α; canakinumab, which is a selective monoclonal antibody against interleukin 1β (IL-1β); anakinra, which is an IL-1 receptor antagonist; and tocilizumab, which is a monoclonal antibody against IL-6 receptor. Colchicine exerts broad anti-inflammatory effects, such as inhibition of IL-1 release. Methotrexate inhibits the p38/mitogen-activated protein kinase (p38/MAPK) pathway, however, it did not prove beneficial in patients with cardiovascular disease. NADPH oxidase: nicotinamide adenine dinucleotide oxidase, Na-K ATPase: sodium-potassium adenosine triphosphatase, JAK: Janus kinase, STAT: signal transducer and activator of transcription
Publication
Cells in Atherosclerosis: Focus on Cellular Senescence from Basic Science to Clinical Practice (2023) Andrea Ágnes Molnár, et al. Int J Mol Sci. 2023 Dec;24(24). Figure: F3.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | IL-1ẞ | IL1 | ncbigene_synonym | IL1A | 3552 |
| Homo sapiens | Primates | IL-1ẞ | IL1 | ncbigene_synonym | IL1B | 3553 |
| Homo sapiens | Primates | IL-10 | IL-10 | ncbigene_synonym | IL10 | 3586 |
| Homo sapiens | Primates | TK | TK | famplex_relations | TK1 | 7083 |
| Homo sapiens | Primates | TK | TK | famplex_relations | TK2 | 7084 |
| Homo sapiens | Primates | IL-6R | IL-6R | ncbigene_synonym | IL6R | 3570 |
| Homo sapiens | Primates | IL-1R | IL1R | ncbigene_synonym | IL1R1 | 3554 |
| Homo sapiens | Primates | TK-R | TKR | ncbigene_synonym | TKTL1 | 8277 |
| Homo sapiens | Primates | GPNMB | GPNMB | ncbigene_symbol | GPNMB | 10457 |
| Homo sapiens | Primates | JAK | JAK | famplex_relations | JAK1 | 3716 |
| Homo sapiens | Primates | JAK | JAK | famplex_relations | JAK2 | 3717 |
| Homo sapiens | Primates | JAK | JAK | famplex_relations | JAK3 | 3718 |
| Homo sapiens | Primates | JAK | JAK | famplex_relations | TYK2 | 7297 |
| Homo sapiens | Primates | STAT | STAT | ncbigene_synonym | SOAT1 | 6646 |
| Homo sapiens | Primates | STAT | STAT | famplex_relations | STAT1 | 6772 |
| Homo sapiens | Primates | STAT | STAT | famplex_relations | STAT2 | 6773 |
| Homo sapiens | Primates | STAT | STAT | famplex_relations | STAT3 | 6774 |
| Homo sapiens | Primates | STAT | STAT | famplex_relations | STAT4 | 6775 |
| Homo sapiens | Primates | STAT | STAT | famplex_relations | STAT6 | 6778 |
| Homo sapiens | Primates | STAT | STAT | famplex_relations | STAT5A | 6776 |
| Homo sapiens | Primates | STAT | STAT | famplex_relations | STAT5B | 6777 |
| Homo sapiens | Primates | AKT | AKT | ncbigene_synonym | AKT1 | 207 |
| Homo sapiens | Primates | AKT | AKT | famplex_relations | AKT2 | 208 |
| Homo sapiens | Primates | AKT | AKT | famplex_relations | AKT3 | 10000 |
| Homo sapiens | Primates | BCL-2 | BCL-2 | ncbigene_synonym | BCL2 | 596 |
| Homo sapiens | Primates | mTOR | MTOR | ncbigene_symbol | MTOR | 2475 |
| Homo sapiens | Primates | FOXO4) | FOXO4 | ncbigene_symbol | FOXO4 | 4303 |
| Homo sapiens | Primates | UPAR | UPAR | ncbigene_synonym | PLAUR | 5329 |
| Homo sapiens | Primates | UPA | UPA | ncbigene_synonym | PLAU | 5328 |
| Homo sapiens | Primates | UPA | UPA | ncbigene_synonym | PRAP1 | 118471 |
| Homo sapiens | Primates | CAR-T | CART | ncbigene_synonym | CARTPT | 9607 |
| Homo sapiens | Primates | ARB | ARB | ncbigene_synonym | BEST1 | 7439 |
| Homo sapiens | Primates | AT-1R | AT1R | ncbigene_synonym | AGTR1 | 185 |
| Homo sapiens | Primates | NADPH | NADPH | ncbigene_synonym | DECR1 | 1666 |
| Homo sapiens | Primates | p38/MAPK | P38 | ncbigene_synonym | CRK | 1398 |
| Homo sapiens | Primates | p38/MAPK | P38 | ncbigene_synonym | MAPK14 | 1432 |
| Homo sapiens | Primates | p38/MAPK | P38 | ncbigene_synonym | MAPK1 | 5594 |
| Homo sapiens | Primates | p38/MAPK | P38 | ncbigene_synonym | AIMP2 | 7965 |
| Homo sapiens | Primates | p38/MAPK | P38 | ncbigene_synonym | GRAP2 | 9402 |
| Homo sapiens | Primates | p38/MAPK | P38 | ncbigene_synonym | AHSA1 | 10598 |
| Homo sapiens | Primates | p38/MAPK | P38 | ncbigene_synonym | POLDIP2 | 26073 |
| Homo sapiens | Primates | p38/MAPK | P38 | famplex_relations | MAPK11 | 5600 |
| Homo sapiens | Primates | p38/MAPK | P38 | famplex_relations | MAPK12 | 6300 |
| Homo sapiens | Primates | p38/MAPK | P38 | famplex_relations | MAPK13 | 5603 |
| Homo sapiens | Primates | p38/MAPK | MAPK | famplex_relations | MAPK3 | 5595 |
| Homo sapiens | Primates | p38/MAPK | MAPK | famplex_relations | MAPK8 | 5599 |
| Homo sapiens | Primates | p38/MAPK | MAPK | famplex_relations | MAPK9 | 5601 |
| Homo sapiens | Primates | p38/MAPK | MAPK | famplex_relations | MAPK10 | 5602 |
| Homo sapiens | Primates | p53 | P53 | ncbigene_synonym | TP53 | 7157 |
| Homo sapiens | Primates | p53 | P53 | famplex_relations | TP63 | 8626 |
| Homo sapiens | Primates | p53 | P53 | famplex_relations | TP73 | 7161 |
| Homo sapiens | Primates | NF-kB | NF-KB | ncbigene_synonym | NFKB1 | 4790 |
| Homo sapiens | Primates | SASP | SASP | ncbigene_synonym | ASPRV1 | 151516 |
| Homo sapiens | Primates | Na-K | NAK | ncbigene_synonym | TBK1 | 29110 |
| Homo sapiens | Primates | Na-KATPase | NAKATPASE | famplex_relations | ATP1A1 | 476 |
| Homo sapiens | Primates | Na-KATPase | NAKATPASE | famplex_relations | ATP1A2 | 477 |
| Homo sapiens | Primates | Na-KATPase | NAKATPASE | famplex_relations | ATP1A3 | 478 |
| Homo sapiens | Primates | Na-KATPase | NAKATPASE | famplex_relations | ATP1A4 | 480 |
| Homo sapiens | Primates | Na-KATPase | NAKATPASE | famplex_relations | ATP1B1 | 481 |
| Homo sapiens | Primates | Na-KATPase | NAKATPASE | famplex_relations | ATP1B2 | 482 |
| Homo sapiens | Primates | Na-KATPase | NAKATPASE | famplex_relations | ATP1B3 | 483 |
| Homo sapiens | Primates | Na-KATPase | NAKATPASE | famplex_relations | ATP1B4 | 23439 |
| Homo sapiens | Primates | ATPase | ATPASE | ncbigene_synonym | DNAH8 | 1769 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| Dasatinib | dasatinib | 4-[6-({5-[(2-chloro-6-methylphenyl)carbamoyl]-1,3-thiazol-2-yl}amino)-2-methylpyrimidin-4-yl]-1-(2-hydroxyethyl)piperazin-1-ium | chebi:190514 | |
| Quercetin | quercetin | 2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-4-oxo-4-chromen-7-olate | chebi:57694 | |
| Rapamycin | rapamycin | (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone | chebi:9168 | |
| Metformin | metformin | N,N-dimethyltriimidodicarbonic diamide | chebi:6801 | |
| nucleus | nucleus | nucleus | chebi:33252 | |
| ROS | ROS | chebi:26523 | ||
| NADPH | NADPH | 2'-O-phosphonatoadenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate} | chebi:57783 | |
| Methotrexate | methotrexate | methotrexate | chebi:50681 | |
| Resveratrol | Resveratrol | trans-resveratrol | chebi:45713 | |
| DNA | DNA | deoxyribonucleic acids | chebi:16991 | |
| Aspirin | Aspirin | 2-(acetyloxy)benzoic acid | chebi:15365 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|